DK1558622T3 - Fremgangsmåde til oprensning af macrolider - Google Patents

Fremgangsmåde til oprensning af macrolider

Info

Publication number
DK1558622T3
DK1558622T3 DK04779384T DK04779384T DK1558622T3 DK 1558622 T3 DK1558622 T3 DK 1558622T3 DK 04779384 T DK04779384 T DK 04779384T DK 04779384 T DK04779384 T DK 04779384T DK 1558622 T3 DK1558622 T3 DK 1558622T3
Authority
DK
Denmark
Prior art keywords
purifying
macrolide
macrolides
purifying macrolides
eluting
Prior art date
Application number
DK04779384T
Other languages
English (en)
Inventor
Vilmos Keri
Zoltan Czovek
Ferenc Rantal
Andrea Csorvasi
Original Assignee
Teva Gyogyszergyar Zartkoeruee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszergyar Zartkoeruee filed Critical Teva Gyogyszergyar Zartkoeruee
Application granted granted Critical
Publication of DK1558622T3 publication Critical patent/DK1558622T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
DK04779384T 2003-07-24 2004-07-26 Fremgangsmåde til oprensning af macrolider DK1558622T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49007003P 2003-07-24 2003-07-24
US53936304P 2004-01-26 2004-01-26
PCT/US2004/024318 WO2005010015A1 (en) 2003-07-24 2004-07-26 Method of purifying macrolides

Publications (1)

Publication Number Publication Date
DK1558622T3 true DK1558622T3 (da) 2008-02-25

Family

ID=34107827

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04779384T DK1558622T3 (da) 2003-07-24 2004-07-26 Fremgangsmåde til oprensning af macrolider

Country Status (13)

Country Link
US (2) US7220357B2 (da)
EP (1) EP1558622B1 (da)
JP (1) JP2007521013A (da)
KR (1) KR20060052874A (da)
AT (1) ATE378345T1 (da)
CA (1) CA2533548C (da)
DE (1) DE602004010059T2 (da)
DK (1) DK1558622T3 (da)
ES (1) ES2297481T3 (da)
PL (1) PL1558622T3 (da)
PT (1) PT1558622E (da)
TW (1) TW200523266A (da)
WO (1) WO2005010015A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003286417A1 (en) * 2003-12-05 2005-06-24 Biocon Limited Process for the purification of macrolides
JP2007519757A (ja) 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ ピメクロリマスの調製方法
US20060149057A1 (en) * 2004-12-22 2006-07-06 Vilmos Keri Method of purifying macrolides
JP2009518648A (ja) * 2005-12-07 2009-05-07 ワイス 結晶性ラパマイシンを調製するための方法およびを示差走査熱量測定使用してラパマイシン化合物の結晶化度を測定するための方法
KR100859670B1 (ko) * 2006-09-13 2008-09-23 동국제약 주식회사 타크로리무스를 고수율 및 고순도로 정제하는 방법
CA2668134A1 (en) * 2006-11-06 2008-05-15 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof
KR100891313B1 (ko) * 2007-08-17 2009-03-31 (주) 제노텍 담체로 작용하는 흡착성 수지의 제공에 의한 트리사이클로화합물의 생산 및 추출 방법
WO2010121203A1 (en) 2009-04-16 2010-10-21 Ocean Spray Cranberries, Inc. Phenolics extraction and use
CN106478664B (zh) * 2016-08-29 2017-12-05 广东蓝宝制药有限公司 一种发酵液中提取纯化他克莫司的方法
PL3619215T3 (pl) 2017-05-01 2022-03-21 Meda Pharma Gmbh & Co. Kg Sposób przekształcania surowej askomycyny w oczyszczony pimecrolimus
CN108409751A (zh) * 2018-02-24 2018-08-17 海正药业(杭州)有限公司 一种子囊霉素的纯化方法
CN111693635A (zh) * 2020-07-23 2020-09-22 北京和合医学诊断技术股份有限公司 检测血液中雷帕霉素含量的方法
CN113325108B (zh) * 2021-06-04 2022-12-09 山东霆科药业有限公司 一种他克莫司软膏的样品前处理方法
CN115716839A (zh) * 2022-11-15 2023-02-28 无锡福祈制药有限公司 一种依维莫司杂质的合成方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2121517C3 (de) 1971-04-30 1974-06-27 Leningradskij Nautschno-Issledowatelskij Institut Antibiotikow, Ssr, Leningrad (Sowjetunion) Verfahren zur Gewinnung von Amphoterizin B
US3993749A (en) * 1974-04-12 1976-11-23 Ayerst Mckenna And Harrison Ltd. Rapamycin and process of preparation
US4160861A (en) * 1977-10-03 1979-07-10 Merck & Co., Inc. Method for the separation of antibiotic macrolides
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
JP2639737B2 (ja) * 1990-01-23 1997-08-13 寳酒造株式会社 新規r106類化合物
US5116756A (en) * 1991-01-28 1992-05-26 Merck & Co., Inc. Process for producing FK-506
EP0582690A1 (en) 1991-04-11 1994-02-16 Pfizer Inc. Novel immunosuppressant agent from streptomyces braegensis
US5091389A (en) * 1991-04-23 1992-02-25 Merck & Co., Inc. Lipophilic macrolide useful as an immunosuppressant
JPH07500613A (ja) * 1992-03-02 1995-01-19 ファイザー・インコーポレーテッド 免疫抑制剤及び抗真菌剤としてのマクロライドのデソサミノ誘導体
UA41884C2 (uk) * 1993-11-05 2001-10-15 Амерікан Хоум Продактс Корпорейшн Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів
US5622866A (en) * 1994-06-23 1997-04-22 Merck & Co., Inc. Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces
GB9618952D0 (en) 1996-09-11 1996-10-23 Sandoz Ltd Process
GB9826882D0 (en) 1998-12-07 1999-01-27 Novartis Ag Organic compounds
TW553946B (en) * 1999-09-08 2003-09-21 Fujisawa Pharmaceutical Co Method for separating lactone-containing high-molecular weight compounds
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
FR2803307A1 (fr) * 1999-12-30 2001-07-06 Centre Nat Rech Scient Lignees de lymphocytes t cd4 specifiques de type th1 et procede pour leur induction ex vivo
CZ20022779A3 (cs) * 2000-02-24 2003-02-12 Biogal Gyogyszergyar Rt. Způsob purifikace fermentačního bujónu
AUPQ801700A0 (en) * 2000-06-07 2000-06-29 Peplin Research Pty Ltd Enzyme and viral activation
AUPQ923100A0 (en) * 2000-08-07 2000-08-31 Peplin Research Pty Ltd Treatment of prostate cancer
JP4261365B2 (ja) * 2002-02-13 2009-04-30 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 生物学的物質からのマクロライドの抽出方法

Also Published As

Publication number Publication date
US20050027112A1 (en) 2005-02-03
PL1558622T3 (pl) 2008-06-30
CA2533548C (en) 2010-02-16
TW200523266A (en) 2005-07-16
US20070117976A1 (en) 2007-05-24
EP1558622B1 (en) 2007-11-14
US7220357B2 (en) 2007-05-22
KR20060052874A (ko) 2006-05-19
CA2533548A1 (en) 2005-02-03
DE602004010059T2 (de) 2008-09-11
ES2297481T3 (es) 2008-05-01
WO2005010015B1 (en) 2005-03-17
EP1558622A1 (en) 2005-08-03
JP2007521013A (ja) 2007-08-02
DE602004010059D1 (de) 2007-12-27
PT1558622E (pt) 2007-12-04
ATE378345T1 (de) 2007-11-15
WO2005010015A1 (en) 2005-02-03

Similar Documents

Publication Publication Date Title
DK1558622T3 (da) Fremgangsmåde til oprensning af macrolider
TW200716669A (en) Method for the purification of antibodies
ATE469908T1 (de) Verfahren zur herstellung von pimecrolimus
PL2092064T3 (pl) Sposób oczyszczania RNA na skalę preparatywną za pomocą HPLC
DE602005025595D1 (de) Kanalspezifikationsvorrichtung und verfahren
TW200704232A (en) Method and arrangement for improved handover
ATE501617T1 (de) System und verfahren zur leistungssteuerung und fernfunkeinheit
EP1806321A4 (en) ADSORPTION AGENTS, PRODUCTION METHOD AND METHOD FOR PROCESSING OIL-CONTAINING WASTE WATER
EP2099500A4 (en) APPARATUS, METHOD AND SYSTEM FOR TREATING SLUDGE WATER SLUDGE
DE602005017052D1 (de) Filter und Verfahren zur Unterdrückung von Effekten von Nachbarkanalstörungen
WO2006066225A3 (en) Apparatus and method to elute microorganisms from a filter
ATE482579T1 (de) Verfahren und vorrichtung zur funkträgerauswahl bei funkübertragungssystemen
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
WO2008045948A3 (en) Adsorbent composition and method of making same
HK1126410A1 (en) Method of treating clostridium difficile-associated diarrhea
WO2008111488A1 (ja) キセノンの濃縮方法および濃縮装置
IL183241A0 (en) Method for purifying tacrolimus
TW200500125A (en) Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins
CA2426783A1 (en) Non-volatile storage device and control method thereof
HRP20040008B1 (en) Plant and method for purification of water coming from a desulphuration kerosene plant
ATE325191T1 (de) Isolierung von antisense-oligonukleotiden
EP1479655A3 (de) Anlage zur Aufbereitung des Wassers von stehenden Gewässern
WO2000071474A3 (en) Method for biologically purifying waste water having a low nutrients content, as well as apparatus for carrying out such a method
ATE477063T1 (de) Fahrzeug und verfahren zum reinigen von wasserversorgungssystemen
WO2006014148A8 (fr) Procede permettant d'organiser un processus de jeu a action intermittente